Response and Resistance to BCR-ABL1-Targeted Therapies - ScienceDirect
Effect of HSP90AB1 and CC domain interaction on Bcr-Abl protein cytoplasm localization and function in chronic myeloid leukemia cells | Cell Communication and Signaling | Full Text
Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade | Cell Communication and Signaling | Full Text
PDF] Regulatory Molecules and Corresponding Processes of BCR-ABL Protein Degradation | Semantic Scholar
Signaling Pathways Activated by Oncogenic Forms of Abl Tyrosine Kinase* - Journal of Biological Chemistry
Potential Role of Notch Signalling in CD34+ Chronic Myeloid Leukaemia Cells: Cross-Talk between Notch and BCR-ABL | PLOS ONE
Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia | Nature Reviews Cancer
BCR-ABL fusion protein
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia
Figure 1 from Targeting the BCR-ABL Signaling Pathway in Therapy-Resistant Philadelphia Chromosome-Positive Leukemia | Semantic Scholar
Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis: Cell
Stem Cells Portal - Exploiting Unique Biological Features of Leukemia Stem Cells for Therapeutic Benefit (http://bit.ly/2VYYIHu) BCR-ABL changes activities of some signaling pathways independently of its kinase activity. Inhibition of BCR-ABL kinase
Effect of dasatinib on the BCR-ABL signaling pathway. Phosphorylation... | Download Scientific Diagram